Skip to content
Browse
LatestWorldBusinessSci & TechEntertainmentSportsHealthGames

Edition

GLGlobalUSUSACACanadaUKUKINIndiaPKPakistanSGSingaporeAUAustralia

Sections

Appearance

AboutSourcesContactPrivacy

Alembic Pharma Q2 net surges 81% to ₹335 crore

“U.S. business was driven by strong volume growth and new launches. In U.S. Branded, we are encouraged by the traction building across our existing portfolio,” said

First reported by The Hindu 1 source
Image: The Hindu
Image: The Hindu
Read at The Hindu(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. The Hindu

    Alembic Pharma Q2 net surges 81% to ₹335 crore (opens The Hindu in a new tab)

    “U.S. business was driven by strong volume growth and new launches. In U.S. Branded, we are encouraged by the traction building across our existing portfolio,” said

Something wrong with how we've grouped or summarised this story? Report a problem

More in Business

More